Pregabalin-associated Discontinuation Symptoms: A Case Report

Pregabalin is used for the treatment of neuropathic pain, partial seizures, generalized anxiety disorder, social anxiety disorder, and insomnia. The discontinuation symptoms of pregabalin are mild to moderate which resolve in about one week after the discontinuation of pregabalin. This case report d...

Descripción completa

Detalles Bibliográficos
Autores principales: Naveed, Sadiq, Faquih, Amber E, Chaudhary, Amna Mohyud Din
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2018
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284877/
https://www.ncbi.nlm.nih.gov/pubmed/30542635
http://dx.doi.org/10.7759/cureus.3425
_version_ 1783379386275201024
author Naveed, Sadiq
Faquih, Amber E
Chaudhary, Amna Mohyud Din
author_facet Naveed, Sadiq
Faquih, Amber E
Chaudhary, Amna Mohyud Din
author_sort Naveed, Sadiq
collection PubMed
description Pregabalin is used for the treatment of neuropathic pain, partial seizures, generalized anxiety disorder, social anxiety disorder, and insomnia. The discontinuation symptoms of pregabalin are mild to moderate which resolve in about one week after the discontinuation of pregabalin. This case report describes the withdrawal symptoms in a 62-year-old patient despite a slow titration over a period of several weeks. It highlights the importance of cautious monitoring of withdrawal symptoms during the period of taper.
format Online
Article
Text
id pubmed-6284877
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-62848772018-12-12 Pregabalin-associated Discontinuation Symptoms: A Case Report Naveed, Sadiq Faquih, Amber E Chaudhary, Amna Mohyud Din Cureus Internal Medicine Pregabalin is used for the treatment of neuropathic pain, partial seizures, generalized anxiety disorder, social anxiety disorder, and insomnia. The discontinuation symptoms of pregabalin are mild to moderate which resolve in about one week after the discontinuation of pregabalin. This case report describes the withdrawal symptoms in a 62-year-old patient despite a slow titration over a period of several weeks. It highlights the importance of cautious monitoring of withdrawal symptoms during the period of taper. Cureus 2018-10-08 /pmc/articles/PMC6284877/ /pubmed/30542635 http://dx.doi.org/10.7759/cureus.3425 Text en Copyright © 2018, Naveed et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Naveed, Sadiq
Faquih, Amber E
Chaudhary, Amna Mohyud Din
Pregabalin-associated Discontinuation Symptoms: A Case Report
title Pregabalin-associated Discontinuation Symptoms: A Case Report
title_full Pregabalin-associated Discontinuation Symptoms: A Case Report
title_fullStr Pregabalin-associated Discontinuation Symptoms: A Case Report
title_full_unstemmed Pregabalin-associated Discontinuation Symptoms: A Case Report
title_short Pregabalin-associated Discontinuation Symptoms: A Case Report
title_sort pregabalin-associated discontinuation symptoms: a case report
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6284877/
https://www.ncbi.nlm.nih.gov/pubmed/30542635
http://dx.doi.org/10.7759/cureus.3425
work_keys_str_mv AT naveedsadiq pregabalinassociateddiscontinuationsymptomsacasereport
AT faquihambere pregabalinassociateddiscontinuationsymptomsacasereport
AT chaudharyamnamohyuddin pregabalinassociateddiscontinuationsymptomsacasereport

Ejemplares similares